Clinical Trial Update: Melphalan With BBBD in Treating Patients With Brain Malignancies [Phase 1]

View source ↗

Summary

Phase 1 trial of melphalan with blood-brain barrier disruption for brain tumors and related cancers has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Cancer
• Lymphoma

Drugs mentioned

• Melphalan (Melphalan)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Brain and Central Nervous System Tumors, Lymphoma | Phase 1 | Status: TERMINATED